Literature DB >> 7082116

A clinical approach to hepatitis B.

J W King.   

Abstract

Hepatitis B virus (HBV) infections continue to be a major public health problem. Although the use of sensitive screening tests for hepatitis B surface antigen has reduced the incidence of posttransfusional hepatitis B, sexual transmission and other forms of nonparenteral and parenteral transmission of HBV still occur frequently. Until an effective HBV vaccine is commercially available, physicians will have to rely on accurate serologic diagnosis, education of patients and hospital employees, and the appropriate use of immunoglobulin preparations to alter the spread of this viral infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082116

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

1.  Should dermatologists be immunized against hepatitis B?

Authors:  J G Smith; D K Chalker
Journal:  J Am Acad Dermatol       Date:  1983-02       Impact factor: 11.527

2.  A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.

Authors:  E Z Oddone; P A Cowper; J D Hamilton; J R Feussner
Journal:  Health Serv Res       Date:  1993-04       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.